W8 Severe Asthma (MOC)

You can earn up to 2.0 AMA PRA Category 1 Credit(s). This activity has also been designated by the ABAI for 2.0 MOC Part II Self-Assessment credits. Cost: $40 $20 for College Members, $60 $30 for non-members.

This workshop will discuss the evaluation process and approach to management of difficult to control asthma in children.

Release Date: 12/15/2015
Expiration Date: 12/14/2018

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

• Describe how severe asthmatics are uniquely different and review the evaluation/assessment of these patients, comparing pediatric and adult and develop a treatment plan for patients with severe asthma

Additional information
Disclosure: 

Leonard B. Bacharier, MD, FACAAI -- Consultant/Advisor: Boehringer Ingelheim, DBV Technologies, GlaxoSmithKline, Meda,Teva; Speaker: AstraZeneca, Novartis 

Reynold A. Panettieri, Jr., MD -- Consultant/Advisor: AstraZeneca, Johnson & Johnson; Supported/Contracted Research: Gilead, Johnson & Johnson, Merck, Roche, Sanofi

Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Attendance
  • 2.00 MOC
Course opens: 
12/15/2015
Course expires: 
12/14/2018
Cost:
$30.00
Rating: 
0

Leonard B. Bacharier, MD, FACAAI 

Reynold A. Panettieri, MD

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Attendance
  • 2.00 MOC

Accreditation Period

Course opens: 
12/15/2015
Course expires: 
12/14/2018

Price

Cost:
$30.00
Please login or create an account to take this course.